Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians

Chronic Respiratory Disease

Volumn 12, Issue 2, 2015, Pages 85-92

  Janssen, Daisy J A ^a,b   De Hosson, S M ^c   Bij De Vaate, Eline ^d   Mooren, Kris J M ^e   Baas, Albert A F ^f  

^a CIRO+   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Wilhelmina Ziekenhuis   (Netherlands)

^d Merem Asthma Center Heideheuvel   (Netherlands)

^e Department of Orthopaedic Surgery   (Netherlands)

^f Ziekenhuis Rivierenland   (Netherlands)

Author keywords

breathlessness; morphine; Opioids; palliative care; symptoms

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG RESISTANCE; DRUG SAFETY; DUTCHMAN; DYSPNEA; E-MAIL; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MEDICATION COMPLIANCE; NETHERLANDS; NORMAL HUMAN; OUTPATIENT CARE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PULMONOLOGIST; REFRACTORY DYSPNEA; RESIDENT; RESPIRATION DEPRESSION; AGED; AMBULATORY CARE; CLINICAL PRACTICE; COMPLICATION; CROSS-SECTIONAL STUDY; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; PALLIATIVE THERAPY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; AMBULATORY CARE; ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PALLIATIVE CARE; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE PATTERNS, PHYSICIANS'; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84930359448     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972315571926     Document Type: Article

References (33)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012 ; 380: 2095-2128
2. Lanken PN, Terry PB, Delisser HM, et al. An official American thoracic society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008 ; 177: 912-927
3. World Health Organization. WHO definition of palliative care, http://www.who.int/cancer/palliative/definition/en (2002, accessed 12 January 2013).
4. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000 ; 55: 1000-1006
5. Janssen DJ, Spruit MA, Uszko-Lencer NH, et al. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med. 2011 ; 14: 735-743
6. Janssen DJ, Franssen FM, Wouters EF, et al. Impaired health status and care dependency in patients with advanced COPD or chronic heart failure. Qual Life Res. 2011 ; 20: 1679-1688
7. Gysels MH, Higginson IJ. Caring for a person in advanced illness and suffering from breathlessness at home: threats and resources. Palliat Support Care. 2009 ; 7: 153-162
8. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002 ; 57: 939-944
9. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003 ; 327: 523-528
10. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011 ; 42: 388-399
11. Mahler DA, Selecky PA, Harrod CG, et al. American college of chest physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010 ; 137: 674-691
12. Au DH, Udris EM, Fihn SD, et al. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med. 2006 ; 166: 326-331
13. Rocker G, Young J, Donahue M, et al. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. CMAJ. 2012 ; 184: E497 - E504
14. Young J, Donahue M, Farquhar M, et al. Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists. Can Fam Phys. 2012 ; 58: e401 - e407
15. Altman DG, Gore SM, Gardner MJ, et al. Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed). 1983 ; 286: 1489-1493
16. BaasAAFZyliczZHesselmannGM. Pallialine richtlijn dyspnoe en hoesten 2.0, http://www.pallialine.nl/dyspnoe (2010, accessed 2 May 2014).
17. Gaspar C, Alfarroba S, Telo L, et al. End-of-life care in COPD: a survey carried out with Portuguese Pulmonologists. Revista Portuguesa De Pneumologia. 2014 ; 20: 123-130
18. Hadjiphilippou S, Odogwu SE, Dand P. Doctors' attitudes towards prescribing opioids for refractory dyspnoea: a single-centred study. BMJ Support Palliat Care. 2014 ; 4: 190-192
19. Rocker GM, Simpson AC, Joanne Young B, et al. Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes. CMAJ Open. 2013 ; 1: E27 - E36
20. Clemens KE, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage. 2007 ; 33: 473-481
21. Clemens KE, Klaschik E. Effect of hydromorphone on ventilation in palliative care patients with dyspnea. Support Care Cancer. 2008 ; 16: 93-99
22. Clemens KE, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study. Support Care Cancer. 2009 ; 17: 367-377
23. Mazzocato C, Buclin T, Rapin CH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol. 1999 ; 10: 1511-1514
24. Eiser N, Denman WT, West C, et al. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. Eur Respir J. 1991 ; 4: 926-931
25. Poole PJ, Veale AG, Black PN. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 ; 157: 1877-1880
26. Light RW, Muro JR, Sato RI, et al. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989 ; 139: 126-133
27. Ekstrom MP, Bornefalk-Hermansson A, Abernethy AP, et al. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ. 2014 ; 348: g445
28. Currow DC, Plummer J, Frith P, et al. Can we predict which patients with refractory dyspnea will respond to opioids?. J Palliat Med. 2007 ; 10: 1031-1036
29. Johnson MJ, Bland JM, Oxberry SG, et al. Opioids for chronic refractory breathlessness: patient predictors of beneficial response. Eur Respir J. 2013 ; 42: 758-766
30. Simon ST, Koskeroglu P, Gaertner J, et al. Fentanyl for the relief of refractory breathlessness: a systematic review. J Pain Symptom Manage. 2013 ; 46: 874-886
31. Hui D, Xu A, Frisbee-Hume S, et al. Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial. J Pain Symptom Manage. 2014 ; 47: 209-217
32. Jensen D, Alsuhail A, Viola R, et al. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage. 2012 ; 43: 706-719
33. Simon ST, Niemand AM, Benalia H, et al. Acceptability and preferences of six different routes of drug application for acute breathlessness: a comparison study between the United Kingdom and Germany. J Palliat Med. 2012 ; 15: 1374-1381